NCT00261677View on ClinicalTrials.gov

A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

PHASE3CompletedINTERVENTIONAL

Enrollment

224

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

October 31, 2003

Conditions

AnemiaHodgkin DiseaseLeukemiaLymphoma, Non-hodgkin

Interventions

DRUG

epoetin alfa

All Listed Sponsors

lead

Ortho Biotech Products, L.P.

INDUSTRY

NCT00261677 - A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy | Biotech Hunter | Biotech Hunter